Business News • PR NewsWire • Veridex, LLC Announces Collaboration to Develop Next-Generation Circulating Tumor Cell (CTC) Technology with Massachusetts General Hospital

Veridex, LLC Announces Collaboration to Develop Next-Generation Circulating Tumor Cell (CTC) Technology with Massachusetts General Hospital

Veridex, LLC Announces Collaboration to Develop Next-Generation Circulating Tumor Cell (CTC) Technology with Massachusetts General Hospital

RARITAN, N.J., Jan. 3, 2011 /PRNewswire/ -- Veridex, LLC (Veridex) today announced a collaboration with Massachusetts General Hospital to develop and commercialize a next-generation circulating tumor cell (CTC) technology for capturing, counting and characterizing tumor cells found in patients' bloo

View More : http://www.prnewswire.com/news-releases/veridex-llc-announces-collaboration-to-develop-next-generation-circulating-tumor...

Releted News by prnewswire

Magic Software Expands Presence in Turkey with New Distributor

CarWoo! Predicts Toyota Camry as Online Best Seller For 2011 - Unveils Top Five 2011 Picks

Saint-Gobain Finalizes the Divestiture of its Advanced Ceramics Business

Veridex, LLC Announces Collaboration to Develop Next-Generation Circulating Tumor Cell (CTC) Technology with Massachusetts General Hospital

Absolute Life Solutions Appoints Sy Stern as Independent Director

Statement by Michael J. Williams, President and Chief Executive Officer, on the Bank of America Repurchase Agreement